A. Selma Dagtas
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Albert Einstein College of Medicine (2002); Arkansas Children's Hospital (2009); Bipar (2001)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
A. Selma Dagtas's research focuses on the biological effects of natural compounds, particularly Nigella sativa extract, on cancer cells. Her work investigates the mechanisms by which these compounds may induce cell death in pre-malignant and malignant oral squamous cell carcinoma. Dagtas has published work in this area, with a recent publication in 2021 detailing the cytotoxic effects of Nigella sativa on oral cancer cell lines. Her scholarship metrics include an h-index of 8, with 8 total publications and over 1,000 citations. She has collaborated with Robert Griffin from the University of Arkansas for Medical Sciences on shared publications, contributing to her research network.
Metrics
- h-index: 8
- Publications: 8
- Citations: 1,027
Selected Publications
-
Nigella sativa extract kills pre-malignant and malignant oral squamous cell carcinoma cells (2021)
-
Histone deacetylase inhibitor uses p21Cip1 to maintain anergy in CD4+ T cells (2009)
-
p21<sup>Cip1</sup> up‐regulated during histone deacetylase inhibitor‐induced CD4<sup>+</sup> T‐cell anergy selectively associates with mitogen‐activated protein kinases (2009)
Collaboration Network
Top Collaborators
- Nigella sativa extract kills pre-malignant and malignant oral squamous cell carcinoma cells
Similar Researchers
Based on overlapping research topics